CLINICAL_TRIALS
withdrawal
· 2022-08-17
Clinical Trial Update: Comparisons of the Impact of Duloxetine Versus Imipramine on Therapeutic Efficacy, Psychological Distress, Sexual Function, Urethral and Bladder Wall Structure and Blood Flow in Women With Stress Urinary Incontinence: a Randomized Controlled Study [Phase 3]
Summary
Phase 3 randomized trial comparing duloxetine vs imipramine in women with stress urinary incontinence was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Far Eastern Memorial Hospital | Conditions: Stress Urinary Incontinence | Phase 3 | Status: WITHDRAWN